Drug details
Mylotarg (gemtuzumab ozogamicin for injection)
type of Antineoplastics, Antibiotic
Mylotarg (gemtuzumab ozogamicin for injection) is a cancer medication used to treat acute myeloid leukemia, a type of blood cancer. Mylotarg is usually given to people who are at least 60 years old and have a relapse of their disease and who cannot receive other cancer medications. The brand name Mylotarg is discontinued, but generic versions may be available.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- itching,
- fever,
- pale skin,
- lightheadedness,
- shortness of breath,
- dry mouth,
- cough,
- unusual tiredness,
- flu symptoms,
- right-sided upper stomach pain,
- rapid weight gain,
- sudden numbness or weakness (especially on one side of the body),
- feeling cold,
- coughing up blood,
- vomit that looks like coffee grounds,
- skin sores,
- swollen gums,
- trouble swallowing or talking,
- bleeding gums,
- abnormal vaginal bleeding,
- blood in your urine or stools,
- yellowing of the skin or eyes,
- swelling in your arms or legs,
- painful swelling in your midsection,
- sudden severe headache, and
- sores or white patches in or around your mouth,
- bad breath,
- altered sense of taste,
- problem with your speech or vision
The following drugs are related to Mylotarg, either as a replacement or used together:
- Trisenox (arsenic trioxide injection)
- Arzerra (ofatumumab injection)
- Bosulif (bosutinib tablets)
- Sprycel (dasatinib)
- Fludara (fludarabine)
- Oforta (fludarabine phosphate tablets)
- Jakafi (ruxolitinib)
- Mozobil (plerixafor injection)
- Synribo (omacetaxine mepesuccinate)
The following supplements are related to Mylotarg, and may be used together with the drug:
- Melatonin (s.)
- Saccharomyces Boulardii (s.)
- Adenosine (s.)
- Coriolus Mushroom (s.)
- Arsenic (s.)
- Transfer Factor (s.)